Determination of IsoAspartate in a Peptide

Back to all technologies
Download as PDF
In vitro and in vivo isomerization of aspartate (Asp) to isoaspartate (isoAsp) is one of the main routes to protein degradation. Deamidation of asparagine (Asn) can also yield isoAsp via a common succinimide intermediate. Not only can this transformation change the structure and activity of a protein, it can also lead to immunological response. Furthermore, an increase in endogenous isoAsp has been linked to Alzheimer's disease and aging. The body naturally produces enzymes that work to reduce the levels of isoAsp, namely PIMT and PCMT, both of which methylate isoAsp to encourage isomerization to Asp. The spontaneous, post-translational generation of isoAsp poses an immediate problem to the development of protein-bound pharmaceuticals, where shelf life and activity may be directly affected; in fact, isoAsp generation is one of the most common contributors to heterogeneity in a protein-bound drug. Factors that induce the generation of isoAsp include pH, secondary and tertiary protein structure, and formulation.

Researchers at Purdue University have developed a fast and inexpensive method to determine isoaspartate by chemical derivatization in the backbones of peptides by ionizing labeled peptides. This method is the simplest and most accessible assay for isoAsp determination, which makes it useful to researchers studying its link to disease or drug-bioconjugate degradation.

-Easily accessible

Potential Applications:
-Research related to isoAsp's link to disease or drug-bioconjugate degradation
-Pharmaceutical industry
Jun 7, 2018
Utility Patent
United States
Feb 2, 2021

Jan 26, 2021
United States

Jun 7, 2017
United States
Purdue Office of Technology Commercialization
The Convergence Center
101 Foundry Drive, Suite 2500
West Lafayette, IN 47906

Phone: (765) 588-3475
Fax: (765) 463-3486